Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham view

被引：28
|
作者：
Wilson, PWF [1 ]
机构：
[1] Med Univ S Carolina, Dept Endocrinol, Charleston, SC 29425 USA
来源：
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2004年 / 33卷 / 03期
关键词：
D O I：
10.1016/j.ecl.2004.03.012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The metabolic syndrome as currently defined by the Adult Treatment Panel III includes multiple components. This article describes the background for these components' inclusion in the syndrome, measurement of these factors, and the appropriate interventions. The factors are highly interrelated and the true utility of this diagnostic entity is under critical evaluation as new and existing data are evaluated concerning the role of the syndrome in the development of vascular disease and other clinical outcomes.
引用
收藏
页码：467 / +
页数：16
相关论文
共 50 条
  • [1] Cardiovascular disease prediction and type 2 diabetes:: Framingham risk versus metabolic syndrome criteria
    Saumell, J.
    Cabre, J. J.
    Pinol, J. L.
    Baldrich, M.
    Martin, F.
    Costa, B.
    Basora, J.
    [J]. DIABETOLOGIA, 2007, 50 : S147 - S147
  • [2] Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk - The Framingham Heart Study
    Lee, Douglas S.
    Evans, Jane C.
    Robins, Sander J.
    Wilson, Peter W.
    Albano, Irene
    Fox, Caroline S.
    Wang, Thomas J.
    Benjamin, Emelia J.
    D'Agostino, Ralph B.
    Vasan, Ramachandran S.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (01) : 127 - 133
  • [3] Metabolic syndrome and increased risk for cardiovascular disease
    Ciaccio, M
    Bellia, C
    Gorgone, E
    Bivona, G
    Guglielmini, E
    Caruso, A
    Petrigni, T
    Scazzone, C
    Vocca, L
    [J]. CLINICA CHIMICA ACTA, 2005, 355 : S334 - S335
  • [4] Metabolic syndrome - cardiovascular disease risk and more
    Carulli, N
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 : 1 - 2
  • [5] Features of the metabolic syndrome and the risk of cardiovascular disease
    Lamarche, B
    St-Pierre, AC
    [J]. BIOMARKERS, 2005, 10 : S37 - S43
  • [6] Framingham risk score alone underestimates burden of cardiovascular risk in Indian patients with metabolic syndrome
    Kasliwal, R. R.
    Bansal, M.
    Agrawal, V.
    Mehrotra, R.
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 : 783 - 783
  • [7] Cardiovascular risk assessment in metabolic syndrome: view from PROCAM
    Assmann, G
    Nofer, JR
    Schulte, H
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2004, 33 (02) : 377 - +
  • [8] Risk Assessment for Cardiovascular Disease Using the Framingham Risk Score and Globorisk Score Among Newly Diagnosed Metabolic Syndrome Patients
    Adil, Syed Omair
    Uddin, Fareed
    Musa, Kamarul Imran
    Khan, Asima
    Shakeel, Areebah
    Shafique, Kashif
    Islam, Md Asiful
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 4295 - 4305
  • [9] Review Article: An Adipocentric View of the Metabolic Syndrome and Cardiovascular Disease
    Dennedy M.C.
    Vidal-Puig A.
    [J]. Current Cardiovascular Risk Reports, 2014, 8 (3) : 1 - 9
  • [10] Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms
    Zomer, Ella
    Liew, Danny
    Owen, Alice
    Magliano, Dianna J.
    Ademi, Zanfina
    Reid, Christopher M.
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2014, 21 (03) : 384 - 390
12345